Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
Clinical trial NCT02500121 · COMPLETED
Trial details
- NCT number
- NCT02500121
- Sponsor
- Matthew Galsky
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-11
- Primary completion
- 2019-07-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.